[1]
|
Jauch EC,Saver JL,Adams HP Jr,et al.Guidelines for the early management of patients with acute ischemic stroke:a guideline for healthcare professionals from the American Heart Association/American Stroke Association[J].Stroke,2013,44(3):870-947. |
[2]
|
Jin R,Yang G,Li G.Inflammatory mechanisms in ischemic stroke:role of inflammatory cells[J].J Leukoc Biol,2010,87(5):779-789. |
[3]
|
Tsai NW,Lee LH,Huang CR,et al.The association of statin therapy and high-sensitivity C-reactive protein level for predicting clinical outcome in acute non-cardioembolic ischemic stroke[J].Clin Chim Acta,2012,413(23/24):1861-1865. |
[4]
|
Hajsadeghi S,Kashani Amin L,Bakhshandeh H,et al.The diagnostic value of N-terminal pro-brain natriuretic peptide in differentiating cardioembolic ischemic stroke.[J].J Stroke Cerebrovasc Dis,2013,22(4):554-560. |
[5]
|
Banecka-Majkutewicz Z,Sawula W,Kadziński L,et al.Homocysteine,heat shock proteins,genistein and vitamins in ischemic stroke--pathogenic and therapeutic implications[J].Acta Biochim Pol,2012,59(4):495-499. |
[6]
|
Lakhan SE,Kirchgessner A,Hofer M.Inflammatory mechanisms in ischemic stroke:therapeutic approaches[J].J Transl Med,2009,17(7):97. |
[7]
|
Casas JP,Bautista LE,Smeeth L,et al.Homocysteine and stroke:evidence on a causal link from mendelian randomisation[J].Lancet,2005,365(9455):224-232. |
[8]
|
Markus HS,Ali N,Swaminathan R,et al.A common polymorphism in the methylenetetrahydrofolate reductase gene,homocysteine,and ischemic cerebrovascular disease[J].Stroke,1997,28(9):1739-1743. |
[9]
|
Huang Y,Jing J,Zhao XQ,et al.High-sensitivity C-reactive protein is a strong risk factor for death after acute ischemic stroke among Chinese[J].CNS Neurosci Ther,2012,18(3):261-266. |
[10]
|
Purroy F,Montaner J,Molina CA,et al.C-reactive protein predicts further ischemic events in transient ischemic attack patients[J].Acta Neurol Scand,2007,115(1):60-66. |
[11]
|
Di Napoli M,Schwaninger M,Cappelli R,et al.Evaluation of C-reactive protein measurement for assessing the risk and prognosis in ischemic stroke:a statement for health care professionals from the HS-CRP Pooling Project members[J].Stroke,2005,36(6):1316-1329. |
[12]
|
Folsom AR,Nambi V,Bell EJ,et al.Troponin T,N-terminal pro-B-type natriuretic peptide,and incidence of stroke:the atherosclerosis risk in communities study[J].Stroke,2013,44(4):961-967. |
[13]
|
Rodríguez-Yáez M,Arias-Rivas S,Santamaría-Cadavid M,et al.High pro-BNP levels predict the occurrence of atrial fibrillation after cryptogenic stroke[J].Neurology,2013,81(5):444-447. |
[14]
|
董贯忠,钱传中,吴秀梅,等.急性缺血性脑卒中患者血浆N末端脑钠素前体水平变化及其临床意义[J].临床神经病学杂志,2008,21(6):421. |
[15]
|
Ois A,Gomis M,Rodríguez-Campello A,et al.Factors associated with a high risk of recurrence in patients with transient ischemic attack or minor stroke[J].Stroke,2008,39(6):1717-1721. |
[16]
|
张文婷,陈茂刚,张敏,等.缺血性脑卒中复发与相关因素分析[J].中华老年心脑血管病杂志,2012,14(2):168-171. |
[17]
|
Murat Sumer M,Erturk O.Ischemic stroke subtypes:risk factors,functional outcome and recurrence[J].Neurol Sci,2002,22(6):449-454. |
[18]
|
赵红梅,刘文华,王筱萌,等.复发性脑梗死的危险因素及病因学分析[J].中华老年心脑血管病杂志,2013,15(1):42-45. |